Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (Q73019577)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1999

Language	Label	Description	Also known as
English	Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis	scientific article published on 01 October 1999

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

cystic fibrosis

1 reference

based on heuristic

inferred from title

author name string

M W Konstan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S M Butler

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D V Schidlow

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

W J Morgan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J R Julius

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C A Johnson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 October 1999

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Pediatric Pulmonology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

248-254

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Broncoscopy Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

The changing epidemiology of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Effect of high-dose ibuprofen in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Gender gap in cystic fibrosis mortality

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199910%2928%3A4%3C248%3A%3AAID-PPUL3%3E3.0.CO%3B2-N

21 January 2018

Identifiers

10.1002/(SICI)1099-0496(199910)28:4<248::AID-PPUL3>3.0.CO;2-N

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10497373%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73019577&oldid=1956156363"